<> Mangalam Drugs and Organics Share Price Today: Live Mangalam Drugs and Organics Share Price NSE/BSE | 5paisa
MANGALAM

Mangalam Drugs And Organics Share PriceMangalam Drugs and Organics

₹114.00
-0.8 (-0.7%)
As on 05 February, 2023 | 16:21 BSE: 532637 NSE: MANGALAM

Mangalam Drugs And Organics Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Mangalam Drugs and Organics

Start SIP

Mangalam Drugs And Organics Share Price

  • Over 1 Month -16.7%
  • Over 3 Month -16.36%
  • Over 6 Month -20.53%
  • Over 1 Year -15.81%

Mangalam Drugs And Organics Key Statistics

P/E Ratio 11.3
PEG Ratio -1.2
Market Cap Cr 180
Price to Book Ratio 1.2
EPS 12.4
Dividend 0
Relative Strength Index 28.47
Money Flow Index 30.71
MACD Signal -4.98
Average True Range 4.55

Mangalam Drugs And Organics Investment Rating

  • Master Rating:
  • Mangalam Drugs & Orgs. has an operating revenue of Rs. 432.61 Cr. on a trailing 12-month basis. An annual revenue growth of 17% is outstanding, Pre-tax margin of 6% is okay, ROE of 13% is good. The company has a reasonable debt to equity of 17%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 60 which is a FAIR score but needs to improve its earnings, a RS Rating of 24 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 95 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Mangalam Drugs and Organics Financials
IndicatorSep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 108109120
Operating Expenses Qtr Cr 10099111
Operating Profit Qtr Cr 81010
Depreciation Qtr Cr 333
Interest Qtr Cr 343
Tax Qtr Cr 11-2
Net Profit Qtr Cr 237

Mangalam Drugs And Organics Technicals

EMA & SMA

Current Price
₹114.
-0.8 (-0.7%)
  • Bullish Moving Average
  • ___
  • 1
  • Bearish Moving Average
  • ___
  • 15
  • 20 Day
  • 120.66
  • 50 Day
  • 128.22
  • 100 Day
  • 133.17
  • 200 Day
  • 134.9
  • 20 Day
  • 121.8
  • 50 Day
  • 131.02
  • 100 Day
  • 137.5
  • 200 Day
  • 137.1

Mangalam Drugs And Organics Resistance and Support

PIVOT
₹115.14
Resistance
First Resistance 116.47
Second Resistance 118.14
Third Resistance 119.47
RSI 28.47
MFI 30.71
MACD Single Line -4.98
MACD -5.5
Support
First Resistance 113.47
Second Resistance 112.14
Third Resistance 110.47

Mangalam Drugs And Organics Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 92,453 946,719 10.24
Week 115,467 1,533,402 13.28
1 Month 52,496 1,432,103 27.28
6 Month 48,919 2,622,038 53.6

Mangalam Drugs And Organics Result Highlights

Mangalam Drugs and Organics Synopsis

NSE-Medical-Generic Drugs

Mangalam Drugs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 451.07 Cr. and Equity Capital is Rs. 15.83 Cr. for the Year ended 31/03/2022. Mangalam Drugs and Organics Ltd. is a Public Limited Listed company incorporated on 18/04/1972 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1972PLC116413 and registration number is 116413.
Market Cap 180
Sales 433
Shares in Float 0.79
No of funds 5
Yield 0.68
Book Value 1.19
U/D Vol ratio 1
LTDebt / Equity 17
Alpha -0.02
Beta 0.91

Mangalam Drugs and Organics

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 50.32%50.42%50.42%
Foreign Portfolio Investors 0.1%0.1%0.1%
Financial Institutions/ Banks 0.01%
Individual Investors 44.27%44.13%44.18%
Others 5.31%5.35%5.29%

Mangalam Drugs and Organics Management

Name Designation
Mr. Govardhan M Dhoot Chairman & Managing Director
Mr. Brijmohan M Dhoot Whole Time Director
Mr. Rakesh K Milwani Non Exe.Non Ind.Director
Mr. Rukmesh P Dhandhania Independent Director
Mrs. Nidhi S Mundada Independent Director
Mr. Praveen Saxena Independent Director

Mangalam Drugs And Organics Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Mangalam Drugs And Organics Corporate Action

Date Purpose Remarks
2022-11-11 Quarterly Results
2022-08-05 Quarterly Results
2022-05-26 Audited & Quarterly Results
2022-02-04 Quarterly Results
2021-11-12 Quarterly Results

Mangalam Drugs and Organics FAQs

What is Share Price of Mangalam Drugs and Organics ?

Mangalam Drugs and Organics share price is ₹114 As on 05 February, 2023 | 16:07

What is the Market Cap of Mangalam Drugs and Organics ?

The Market Cap of Mangalam Drugs and Organics is ₹180.4 Cr As on 05 February, 2023 | 16:07

What is the P/E ratio of Mangalam Drugs and Organics ?

The P/E ratio of Mangalam Drugs and Organics is 11.3 As on 05 February, 2023 | 16:07

What is the PB ratio of Mangalam Drugs and Organics ?

The PB ratio of Mangalam Drugs and Organics is 1.2 As on 05 February, 2023 | 16:07

Q2FY23